Making the COVID-19 Oral Treatment: How 2,000+ Pfizer Team Members Made It Happen
As the potential threat of COVID-19 became clear by early 2020, teams across Pfizer sprang into action. Together, they worked to better understand the novel virus.
significantly elevated RBD-binding IgG antibodies with geometric mean as measured by RBD-binding IgG concentrations and SARS-CoV-2 …
(CP-751,871), a selective fully human IgG2 monoclonal antibody against the …
molecules called immunoglobulin G, or IgG, through the placenta to her …
ordered multimers of normal human IgG Fc to its receptors. About Gliknik …
Behind the Science Features
Press Releases
07.08.2022
06.30.2022
06.30.2022
06.29.2022
06.28.2022
06.25.2022
06.24.2022
06.23.2022
06.23.2022
06.22.2022
Updates and Statements
06.21.2022
Press Releases, Partnering News
06.20.2022
Media Resources
This information is intended for media professionals. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.
Clinical Trials
Our Careers